V-Co Investors 4 LLC 3
3 · Vivos Therapeutics, Inc. · Filed Jul 15, 2026
Insider Transaction Report
Form 3
V-Co Investors 4 LLC
10% Owner
Holdings
Series A Convertible Preferred Stock
[F1]Exercise: $0.46→ Common Stock (2,749,330 underlying)Common Stock Purchase Warrant
Exercise: $0.46From: 2026-06-30Exp: 2031-06-30→ Common Stock (2,749,330 underlying)
Footnotes (1)
- [F1]The convertible preferred stock is convertible at any time, at the holder's election, subject to a beneficial ownership limitation, and has no expiration date.
Signature
/s/ Michael C. Skaff, as Managing Director SP manager LLC, Manager of V-Co Investors 4 LLC|2026-07-15